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The relationship between body size and mortality
in the linked Scottish Health Surveys: cross-sectional
surveys with follow-up
JW Hotchkiss and AH Leyland
MRC/CSO Social and Public Health Sciences Unit, Glasgow, UK
Objective: To investigate the relationship between body mass index (BMI), waist circumference (WC) or waist–hip ratio (WHR)
and all-cause mortality or cause-specific mortality.
Design: Cross-sectional surveys linked to hospital admissions and death records.
Subjects: In total, 20117 adults (aged 18–86 years) from a nationally representative sample of the Scottish population.
Measurements: Cox proportional hazards models were used to estimate hazard ratios (HRs) for all-cause, or cause-specific,
mortality. The three anthropometric measurements BMI, WC and WHR were the main variables of interest. The following were
adjustment variables: age, gender, smoking status, alcohol consumption, survey year, social class and area of deprivation.
Results: BMI-defined obesity (X30kgm
 2) was not associated with increased risk of mortality (HR¼0.93; 95% confi-
dence interval¼0.80–1.08), whereas the overweight category (25–o30kgm
 2) was associated with a decreased risk (0.80;
0.70–0.91). In contrast, the HR for a high WC (menX102cm, womenX88cm) was 1.17 (1.02–1.34) and a high WHR (menX1,
womenX0.85) was 1.34 (1.16–1.55). There was an increased risk of cardiovascular disease (CVD) mortality associated with
BMI-defined obesity, a high WC and a high WHR categories; the HR estimates for these were 1.36 (1.05–1.77), 1.41 (1.11–1.79)
and 1.44 (1.12–1.85), respectively. A low BMI (o18.5kgm
 2) was associated with elevated HR for all-cause mortality (2.66;
1.97–3.60), for chronic respiratory disease mortality (3.17; 1.39–7.21) and for acute respiratory disease mortality (11.68;
5.01–27.21). This pattern was repeated for WC but not for WHR.
Conclusions: It might be prudent not to use BMI as the sole measure to summarize body size. The alternatives WC and WHR
may more clearly define the health risks associated with excess body fat accumulation. The lack of association between elevated
BMI and mortality may reflect the secular decline in CVD mortality.
International Journal of Obesity (2011) 35, 838–851; doi:10.1038/ijo.2010.207; published online 5 October 2010
Keywords: body mass index; waist circumference; waist–hip ratio; mortality; epidemiology
Introduction
Obesity is a major health challenge of the 21st Century with
rising worldwide prevalence in recent decades. One estimate
is that 1 in 13 deaths in Europe is related to excess weight.
1
A U- or J-shaped association between body mass index (BMI)
and mortality has frequently been described.
2–5 BMI is a
measure of overall obesity, but with known limitations,
including the inability to reflect body fat distribution. This
has prompted the use of waist circumference (WC) or waist–
hip ratio (WHR), both alternative indices that are believed to
be proxies for abdominal adiposity.
6
Relatively few cross-sectional, nationally representative
studies have been published regarding the potential impact
on mortality of obesity, as identified using measured
anthropometric indices, for example papers by Katzmarzyk
et al.
4 and Flegal et al.
2,7 The Scottish Health Surveys (SHeSs)-
linked data set provides an opportunity to do this. According
to the 2008 SHeS, the prevalence of obesity in Scotland was
26.0% in men and 27.5% in women,
8 and one study using
the 1998 SHeS identified that both obesity and underweight
were associated with an increased risk of serious hospital
admission.
9 We aimed to investigate the relationship
between body size and mortality, while adjusting for
confounders such as smoking and alcohol consumption that
might have an influence on mortality. The SHeSs also
permitted the investigation of whether or not body size
identifies additional risk to the accumulated risk factors
reflected in socioeconomic status or area of deprivation.
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www.nature.com/ijoThis was important because of the pronounced socio-
economic gradients for mortality
10 and separately for
obesity, especially for women.
11 The objective of this study
was to examine the association of body size with all-cause
and cause-specific mortality using BMI, WC or WHR in a
representative sample of the Scottish population using
commonly used and understood categories.
Methods
Survey method and subjects
The SHeSs 1995, 1998 and 2003 are cross-sectional nation-
ally representative surveys designed to provide reliable
information on the health and health-related behaviours of
people living in private households in Scotland; details of
these surveys are described elsewhere.
12–15 The samples were
selected using a multistage stratified clustered probability
sampling design. The surveys were limited to 16–64 year olds
in 1995 and 2–74 year olds in 1998. In 2003, all ages were
surveyed. Data were collected during two household visits;
first by an interviewer then by a nurse if consent was given.
During the face-to-face interviews, baseline data such as age,
gender, alcohol consumption, smoking status, occupational
social class, height and weight were ascertained. Self-
completed questionnaires were used at the interviewer’s
discretion to determine smoking and alcohol consumption
behaviour in teenagers. Bodyweight was measured to the
nearest 100g using electronic scales. Respondents exceeding
the scales’ upper limit of 130kg were invited to provide an
estimated weight. Height was measured to the nearest
millimetre using a stadiometer. Waist and hip circumfer-
ences were obtained during the nurse visit using a measuring
tape with an insertion buckle. Both were taken at least twice
and recorded to the nearest millimetre to provide a mean.
The waist was defined as the midpoint between the lower rib
and the upper margin of the iliac crest. The hips were
measured at the widest circumference around the buttocks
below the iliac crest. Pregnant women and participants who
were chair bound were excluded from all the above
measurements.
Measures
Anthropometric. BMI was calculated as weight (kg) divided
by the square of the height (m
2). The World Health
Organisation (WHO) principal cutoff points for BMI were
used to create the categories: underweight (o18.5kgm
 2),
desirable weight (18.5–o25kgm
 2), overweight (25–o30
kgm
 2) and obese (X30kgm
 2).
16 WC was defined in
gender-specific low, reference, moderate and high categories
for men equal to o79, 79–o94, 94–o102 and X102cm and
women equal to o68, 68–o80, 80–o88 and X88cm.
17,18
WHR equalled WC divided by hip circumference and was
categorized as low, reference, moderate and high separately
for men o0.85, 0.85–o0.95, 0.95–o1 and X1 and women
o0.7, 0.7–o0.8, 0.8–o0.85 and X0.85. The classifications
for WC and WHR included cutoffs recommended by a WHO
consultation.
16
Covariates. Age was recorded as age at the time of interview.
Smoking status was categorized as never smoker, ex-smoker,
light smoker (0–o10 cigarettes per day), moderate smoker
(10–o20 cigarettes per day) and heavy smoker (X20
cigarettes per day). Pipe and cigar smokers were included
with light smokers. Alcohol consumption was defined as
never or very occasional drinker, ex-drinker, 0–o7 units per
week, 7–o14 units per week, 14–o21 units per week,
21–o28 units per week and X28 units per week. A unit of
alcohol is defined as 10ml (B8g) ethanol. Occupational
social class (Registrar General’s classification) was divided
into six categories I/II, III non-manual, III manual, IV, V and
others (including armed forces/unknown/not able to be
classified/undetermined). Postcode sectors of residence were
categorized into quintiles based on the Carstairs score, an
area-based deprivation measure derived from levels of male
unemployment, manual social class, overcrowding and lack
of car ownership and derived from the 2001 Census.
19
Outcome measures
Respondents were asked for permission for their records to be
linked to National Health Service administrative data. This
enabled the linkage of these surveys to a database of deaths
(to December 2007) and the Scottish Morbidity Records;
both are maintained by the Information Services Division of
National Health Service Scotland.
15 The Scottish Morbidity
Records are a patient-based database of acute and psychiatric
hospital discharges from 1981 to December 2007 along with
cancer registrations from 1981 to December 2005. Specific
cause of death information was available using International
Classification of Diseases, Ninth revision and International
Classification of Diseases-10 codes. This was recoded, using a
standard list of 113 causes of death,
20 into three broad
categories (each with subdivisions) of cardiovascular disease
(CVD), cancer and all other causes (namely non-cancer and
non-CVD deaths) as described by Flegal et al.
7 (Table 1). An
exception was that deaths due to diabetes and kidney disease
were included in miscellaneous causes due to low numbers.
Using their rationale, obesity-related cancers were defined as
colon, breast, oesophageal, uterine, ovarian, kidney or
pancreatic cancers. The SHeSs were linked to the Commu-
nity Health Index (CHI) as at January 2008, to determine
whether respondents had been registered with a Scottish
general practice by the end of the follow-up period.
Sample
Response for the interview stage of the survey declined from
81% in 1995 to 76% in 1998 and finally to 60% in 2003. The
proportion of interviewees that progressed to a second
interview with a nurse also declined from 88% in 1995 to
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to data linkage reducing the combined sample size of the
three surveys (for over 16 year olds) from 25127 to 23093; of
these 1569 had died by December 2007. Only participants
between the ages of 18 and 85 years were included in the
analyses, resulting in a further reduction in sample size to
22426 with 1523 deaths. The proportion of individuals
with missing data was as follows: BMI¼10.2%, WC¼20.3%,
WHR¼20.4%, smoking status¼0.1% and alcohol con-
sumption¼0.1% (Table 2). The missing anthropometric
data included pregnant women (n¼212) who were excluded
from all analyses. The complete cases available for analyses
were as follows: BMI¼20117 subjects (1280 deaths),
WC¼17867 subjects (1220 deaths) and WHR¼17840
subjects (1218 deaths).
Statistical analyses
For each of the anthropometric measures, Cox proportional
hazards models were used to estimate hazard ratios (HRs) for
all-cause, or cause-specific, mortality in a data set consisting
of the three surveys combined. They were fitted within a
multilevel framework to account for the data hierarchy of
individuals within postcodes. The timescale was taken as the
time since interview (months) and censoring occurred on 31
December 2007. The alternative approach of using age as the
timescale was also investigated using a single level model.
The following covariates were included in all models: age
(centred), gender, smoking status, alcohol consumption and
survey cohort. These models were then further adjusted for
either individual social class or Carstairs area of deprivation.
The second lowest category was used as referent for the
anthropometric covariates; all other categorical covariates
used the first category. Interactions between all covariables
were explored. Stratification by gender and age groups
(18–39, 40–64 and X65 years) was performed. Adherence
to the proportional hazards assumption was investigated by
incorporation of time-dependent covariates in the models
and by plotting smoothed Schoenfeld residuals against
time; no violations of the assumption were identified.
All statistical tests were two tailed, and statistical significance
was taken as Po0.05.
We assumed that the missing anthropometric data were
missing at random, that is the probability that data were
missing was dependent on observed variables. This assump-
tion prompted us to investigate the association between
missing data and observed variables. The relationship bet-
ween missing data for BMI, WC and WHR and survival time
was explored using Cox proportional hazards model adjusted
for age, gender, survey year, smoking and alcohol consump-
tion. Mutually adjusted logistic regression models were used
to investigate the association of age, gender, death during
follow-up, survey year, smoking and alcohol consumption
with the binary outcome of missing or not missing BMI, WC
or WHR. In both these exploratory analyses, cases with
missing data for smoking or alcohol consumption were
excluded (n¼25). These cases were also excluded when
multiple imputation was used to replace missing data for
BMI, WC and WHR. Five imputed data sets were created
using a logistic regression method for monotone missing
data (PROC MI in SAS v9.2, SAS Institute Inc., Cary,
NC, USA). The covariates included in the logistic regression
model used to inform the imputation were outcome
(censored or died), age, gender, survey cohort, smoking
status and alcohol consumption. Estimates from multilevel,
multivariable survival analyses using the imputed data sets
were averaged to produce overall estimates and standard
errors were combined using Rubin’s rules.
21
Sensitivity analyses involving sequential, and indepen-
dent, exclusion of previous illness, all ever smokers, early
death during follow-up and individuals 464 years were
performed. Using the linked Scottish Morbidity Records
data, previous illness was defined as having a diagnosis of
cancer or CVD prior to interview. Early death was defined as
death within 2 years of interview. Separate analyses were also
restricted to those who had died or were linked to the CHI in
order to assess the impact of emigration or other alternative
reasons for loss to follow-up. The analyses were also repeated
incorporating survey weights that accounted for dispropor-
tionate sampling, differing probabilities of selection and
differential response. The main analyses were also repeated
restricting the age range to that in the 1995 survey (18–64
years). All the aforementioned analyses were performed
using SAS v9.2 (SAS Institute Inc., Cary, NC, USA) and
MLwiN v2.11
22 statistical software.
The anthropometric measures were also fitted as conti-
nuous variables using fractional polynomials in fully adjusted
single level models for all-cause mortality.
23 Command mfp
in Stata/IC 10.1 (StataCorp LP., College Station, TX, USA)
was used to fit the most appropriate first-degree, or
second-degree, fractional polynomial to the data using the
Table 1 Cause of death categorization for use in cause-specific mortality
analyses
Cause of death Corresponding numbers from 113 causes
of death list
a
CVD 54–74
Coronary heart disease 58–63
Other CVD 55–57, 64–74
Cancer 19–43
Lung cancer 27
Considered obesity related
b 21, 23, 25, 29, 31, 32, 34
All other cancers All other numbers within cancer
category
Non-cancer, non-CVD disease All other numbers
Chronic respiratory disease 82–86
Acute respiratory and infectious
disease
1–18, 76–81, 87–89
Injuries 112–135
MiscellaneousFincluding
diabetes and kidney disease
All other numbers within non-cancer,
non-CVD categories
Abbreviation: CVD, cardiovascular disease.
aBased on Anderson et al.
20
bColon, breast, oesophageal, uterine, ovarian, kidney and pancreatic cancers.
Based on rationale used by Flegal et al.
7
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International Journal of ObesityTable 2 Baseline characteristics for the linked 1995, 1998 and 2003 Scottish Health Surveys, individually, and combined
Survey Combined surveys
1995 1998 2003
Sample size 7170 8115 7141 22426
Number of deaths, n (%)
All-cause 503 (7.0) 735 (9.1) 285 (4.0) 1523 (6.8)
CVD 148 (2.1) 245 (3.0) 116 (1.6) 509 (2.3)
Cancer 185 (2.6) 261 (3.2) 91 (1.3) 537 (2.4)
Non-cancer and non-CVD 170 (2.4) 229 (2.8) 78 (1.1) 477 (2.1)
Person-years of follow-up 85629 71597 27216 184442
Mean age (s.d.) 40.9 (12.9) 45.9 (15.5) 50.1 (16.8) 45.6 (15.6)
Gender, n (%)
Women 3961 (55.2) 4551 (56.1) 3990 (55.9) 12 502 (55.7)
Men 3209 (44.8) 3564 (43.9) 3151 (44.1) 9924 (44.3)
Ethnicity, n (%)
White 7109 (99.1) 8039 (99.1) 7015 (98.2) 22 163 (98.8)
Other 59 (0.8) 69 (0.9) 112 (1.6) 240 (1.1)
Missing 2 (0.0) 7 (0.1) 14 (0.2) 23 (0.1)
BMI (kgm
 2), n (%)
o18.5 (Underweight) 99 (1.4) 116 (1.4) 80 (1.1) 295 (1.3)
18.5–o25 (Desirable weight) 3004 (41.9) 2802 (34.5) 1973 (27.6) 7779 (34.7)
25–o30 (Overweight) 2349 (32.8) 2812 (34.7) 2430 (34.0) 7591 (33.8)
X30 (Obese) 1215 (16.9) 1662 (20.5) 1593 (22.3) 4470 (19.9)
Missing 503 (7.0) 723 (8.9) 1065 (14.1) 2291 (10.2)
WC (cm), n (%)
M o79 W o68 (Low) 875 (12.2) 618 (7.6) 221 (3.1) 1714 (7.6)
M 79–o94 W 68–o80 (Reference) 2910 (40.6) 2750 (33.9) 1547 (21.7) 7207 (32.1)
M 94–o102 W 80–o88 (Moderate) 1292 (18.0) 1532 (18.9) 1285 (18.0) 4109 (18.3)
M X102 W X88 (High) 1212 (16.9) 1818 (22.4) 1824 (25.5) 4854 (21.6)
Missing 881 (12.3) 1397 (17.2) 2264 (31.7) 4542 (20.3)
WHR, n (%)
Mo0.85 W o0.7 (Low) 783 (10.9) 678 (8.4) 308 (4.3) 1769 (7.9)
M 0.85–o0.95 W 0.7–o0.8 (Reference) 3378 (47.1) 3358 (41.4) 2063 (28.9) 8799 (39.2)
M 0.95–o1 W 0.8–o0.85 (Moderate) 1262 (17.6) 1501 (18.5) 1184 (16.6) 3947 (17.6)
M X1WX0.85 (High) 861 (12.0) 1174 (14.5) 1307 (18.3) 3342 (14.9)
Missing 886 (12.4) 1404 (17.3) 2279 (31.9) 4569 (20.4)
Smoking status, n (%)
Never smoker 3074 (42.9) 3236 (39.9) 3039 (42.6) 9349 (41.7)
Ex-smoker 1282 (17.9) 1916 (23.6) 2043 (28.6) 5241 (23.4)
Light smoker 597 (8.3) 650 (8.0) 548 (7.7) 1795 (8.0)
Moderate smoker 1058 (14.8) 1162 (14.3) 792 (11.1) 3012 (13.4)
Heavy smoker 1159 (16.2) 1142 (14.1) 715 (10.0) 3016 (13.4)
Missing F 9 (0.1) 4 (0.1) 13 (0.1)
Alcohol consumption, n (%)
Never/occasional drinker 345 (4.8) 479 (5.9) 471 (6.6) 1295 (5.8)
Ex-drinker 258 (3.6) 397 (4.9) 348 (4.9) 1003 (4.5)
0–o7 units per week 3139 (43.8) 3537 (43.6) 3133 (43.9) 9809 (43.7)
7–o14 units per week 1280 (17.9) 1391 (17.1) 1316 (18.4) 3987 (17.8)
14–o21 units per week 853 (11.9) 885 (10.9) 749 (10.5) 2487 (11.1)
21–o28 units per week 478 (6.7) 494 (6.1) 405 (5.7) 1377 (6.1)
X28 units per week 817 (11.4) 920 (11.3) 711 (10.0) 2448 (10.9)
Missing F 12 (0.1) 8 (0.1) 20 (0.1)
Individual social class, n (%)
I/II-Professional/managerial 1885 (26.3) 2257 (27.8) 2334 (32.7) 6476 (28.9)
III-Skilled non-manual 1577 (22.0) 1750 (21.6) 1555 (21.8) 4882 (21.7)
III-Skilled manual 1487 (20.7) 1661 (20.5) 1327 (18.6) 4475 (20.2)
IV-Partly skilled 1188 (16.6) 1423 (17.5) 1220 (17.1) 3831 (17.0)
V-Unskilled 578 (8.1) 605 (7.5) 471 (6.6) 1654 (7.4)
Other 455 (6.3) 419 (5.2) 234 (3.3) 1108 (4.8)
Carstairs quintile, n (%)
1-Least deprived 1292 (18.0) 1431 (17.7) 1336 (18.7) 4059 (18.1)
2 1496 (20.9) 1640 (20.2) 1716 (24.0) 4852 (21.6)
3 1468 (20.5) 1950 (24.0) 1532 (21.5) 4950 (22.1)
4 1297 (18.1) 1501 (18.5) 1287 (18.0) 4085 (18.2)
5-Most deprived 1613 (22.5) 1585 (19.5) 1270 (17.8) 4468 (19.9)
Missing 4 (0.1) 8 (0.1) F 12 (0.1)
Abbreviations: BMI, body mass index; CVD, cardiovascular disease; M, men; W, women; WC, waist circumference; WHR, waist–hip ratio.
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reciprocal, logarithm, square, cube and linear (no transfor-
mation). Age was simultaneously fitted using the same
selection process.
Results
Descriptive data for the three survey cohorts are provided in
Table 2. In all three surveys, there was a greater proportion of
women sampled (55.7%). The minimal ethnic variation
precluded investigation of its influence. The prevalence of
obesity as defined by BMI increased from 16.9% in 1995, to
20.5% in 1998, to 22.3% in 2003 (Po0.0001). A similar trend
was also visible for the high categories of WC (menX102cm,
womenX88cm) and WHR (menX1, womenX0.85) (Table 2).
In the combined data set, the prevalence of obesity accor-
ding to BMI was 19.9%, whereas the prevalence of high WC
and high WHR was 21.6 and 14.9%, respectively (Table 2).
Gender differences in the distribution of individuals accord-
ing to the different measures was very similar except for
WHR where a greater proportion of women were classed as
having a high WHR (20.2%) compared with men (8.2%)
(data not shown).
Association between BMI and all-cause mortality
There was no increased risk of mortality associated with BMI-
defined obesity (HR¼0.93; 95% confidence interval¼0.80–
1.08) (Table 3). Underweight BMI was associated with
elevated HR for all-cause mortality (2.66; 1.97–3.60), whereas
there was a significantly decreased risk associated with being
overweight (0.80; 0.70–0.91). There was a significant inter-
action between gender and year of survey. Relative to women
in 1995, the HR (95% confidence interval) for mortality
in men decreased from 1.75 (1.44–2.13) in 1995 to 0.92
(0.69–1.22) by 2003. An interaction between age and
smoking status indicated that for a 10-year increase in age,
the risk of mortality was higher for those individuals that
smoked a greater number of cigarettes.
Association between BMI and all-cause mortality after
adjustment for socioeconomic status
Socioeconomic status was associated with mortality using
either the individual or area-based measures (Table 4). Inclu-
sion of socioeconomic status in the models attenuated the
HR of the other variables to a limited extent, most noticeably
for smoking status and for an underweight BMI. The limited
variation at the postcode sector level was partly explained by
adjustment for individual social class, whereas a greater
proportion was explained by the separate inclusion of area of
deprivation (Table 4). Stratification by gender revealed a
steeper social class gradient for men than women, but there
was no evidence of an interaction between BMI and social
class (data not shown).
Association between WC, or WHR, and all-cause mortality
The HR for subjects in the highest categories of WC was 1.17
(1.02–1.34) and of WHR was 1.34 (1.16–1.55) (Table 5).
Other estimates for covariates in the adjusted model were
very similar to those in the BMI-adjusted model (data not
shown). Further adjusting these two measures for social class
or area of deprivation had minimal effect on the estimates
(data not shown). Any variation at the postcode sector
level appeared to be fully explained by adjustment for area of
deprivation. There were no significant interactions in these
two models. There were no significant interactions between
gender, or age, with any of the anthropometric measures.
Age stratification did not significantly alter estimates for any
of the measures (data not shown).
Association between the three anthropometric measures and
cause-specific mortalities
The highest categories of all three measures were associated
with an increased hazard of death caused by CVD (Table 5).
For WC and WHR, the association with mortality was linear
across categories with a positive gradient. The obese category
of BMI was not associated with a significantly increased risk
of coronary heart disease mortality. For deaths caused by
other CVDs, that included stroke, there were no significant
associations for any measure.
The pattern of association for all the anthropometric
measures with cancer-related mortality was broadly similar
to that identified for all-cause mortality. A significant
increased risk was associated with the lowest categories. For
the subcategories of cancer mortality, this significant
association was only maintained in relation to lung cancer
mortality for WC. For deaths caused by obesity-related
cancers, only WHR demonstrated an increased risk in the
highest category.
For the remaining causes of death that were non-cancer
and non-CVD in aetiology participants in the lowest
categories were associated with an increased risk of death
for BMI and WC only. For WHR, there was only a significant
increased risk for those in the high category. Underweight
BMI was associated with elevated HR for acute (11.68;
5.01–27.21) and chronic respiratory disease mortality (3.17;
1.39–7.21); a similar but less extreme pattern was identified
for the low category of WC but not for WHR. For overweight
and obesity as defined by BMI, there was a significant protec-
tive association for chronic respiratory disease mortality.
Multiple imputation and sensitivity analyses
The proportion of missing values for BMI increased from 7%
in 1995 to 14% in 2003; for WC and WHR, this proportion
had increased to 32% by 2003 (Table 2). The participants
with missing data for BMI, WC or WHR had significantly
worse survival times than those with complete data, after
adjusting for age, gender, survey year, smoking and alcohol
consumption (Supplementary Table 1). In the adjusted
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WHR was significantly associated with all the variables
considered, except for smoking in the case of BMI (Supple-
mentary Table 1). The estimates from the logistic regression
models used for imputation are available in Supplementary
Tables 2, 4 and 6.
The distribution of imputed BMI, WC and WHR values was
very similar to that of observed values. Analyses using these
Table 3 Multilevel, multivariate hazard ratios and 95% CIs for all-cause mortality in different BMI categories within a model adjusted for age, gender, smoking
status, alcohol consumption and year of survey
Deaths Hazard ratio (95% CI)
n( % ) n( % )
Fixed
Age (10-year increase) F
a
Gender
Women 11075 (55.1) 593 (46.3) F
b
Men 9042 (44.9) 687 (53.7)
BMI (kgm
 2)
o18.5 (Underweight) 294 (1.5) 49 (3.8) 2.66 (1.97–3.60)
18.5–o25 (Desirable weight) 7765 (38.6) 437 (34.1) 1
25–o30 (Overweight) 7589 (37.7) 474 (37.0) 0.80 (0.70–0.91)
X30 (Obese) 4469 (22.2) 320 (25.0) 0.93 (0.80–1.08)
Smoking status
Never smoked 8406 (41.8) 277 (21.6) F
a
Ex-smoker 4662 (23.2) 373 (29.1)
Light smoker 1610 (8.0) 119 (9.3)
Moderate smoker 2716 (13.5) 221 (17.3)
Heavy smoker 2723 (13.5) 290 (22.7)
Alcohol consumption
Never/occasional drinker 1089 (5.4) 102 (8.0) 1
Ex-drinker 846 (4.2) 112 (8.8) 1.22 (0.92–1.60)
0–o7 units per week 8783 (43.7) 557 (43.5) 0.95 (0.76–1.17)
7–o14 units per week 3613 (18.0) 180 (14.1) 0.84 (0.65–1.07)
14–o21 units per week 2289 (11.4) 106 (8.3) 0.79 (0.59–1.04)
21–o28 units per week 1266 (6.3) 73 (5.7) 0.94 (0.68–1.28)
X28 units per week 2231 (11.1) 150 (11.7) 1.01 (0.77–1.32)
SHeSs
1995 6667 (33.1) 448 (35.0) F
b
1998 7380 (36.7) 626 (48.9)
2003 6070 (30.2) 206 (16.1)
Interactions
Gender*SHeSs
Women*1995 3634 (18.1) 189 (14.8) 1
Women*1998 4100 (20.4) 300 (23.4) 1.01 (0.83–1.23)
Women*2003 3341 (16.6) 104 (8.1) 0.82 (0.63–1.08)
Men*1995 3033 (15.1) 259 (20.2) 1.75 (1.44–2.13)
Men*1998 3280 (16.3) 326 (25.5) 1.50 (1.23–1.84)
Men*2003 2729 (13.6) 102 (8.0) 0.92 (0.69–1.22)
Age (10-year increase)*smoking
Age (10years increase)*never smoked FF 2.53 (2.30–2.79)
Age (10years increase)*ex-smoker FF 3.65 (3.35–3.99)
Age (10years increase)*light smoker FF 5.38 (4.71–6.15)
Age (10years increase)*moderate smoker FF 6.75 (6.06–7.52)
Age (10years increase)*heavy smoker FF 8.24 (7.36–9.23)
Random Estimate s.e.
Variance at postcode sectors level 0.03 0.03
Total, n 20 117 1280
Abbreviations: BMI, body mass index; CI, confidence interval; SHeSs, Scottish Health Surveys.
aInteraction between age and smoking status.
bInteraction between
gender and year of SHeS.
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case models. The largest change in the models was lower HRs
for the lowest categories of BMI (2.38; 1.72–3.27), WC
(1.49; 1.20–1.84) and WHR (1.17; 0.93–1.49) (Supplementary
Tables 3, 5 and 7). From the CHI, it was determined that
6.6% of participants had either migrated outwith Scotland,
were untraceable or had no current link to the index.
Analyses restricted to individuals that were registered on the
CHI generated estimates comparable to those from the
complete case analyses. Use of survey weights in complete
case models for BMI, WC and WHR again provided estimates
that were almost identical except for underweight BMI
where the HR was reduced to 2.30 (1.66–3.18).
Analyses using age as the timescale generated estimates
similar to those using time since interview (Supplementary
Tables 8–11). For the main BMI model (Supplementary Table
8), the interaction between gender and survey year, identi-
fied in the time since interview model, was only just non-
significant for inclusion. Sensitivity analyses sequentially
excluding previous illness, ever smokers, early follow-up and
individuals 464 years increased, rather than decreased, the
HR estimates for underweight BMI (Table 6). Generally,
sequential exclusions had the effect of reducing HR estimates
towards unity for the lowest category of WC whereas risks
increased for the highest category, although these estimates
were almost all non-significant. This was also the case
for WHR, and following exclusion of the first 2 years of
follow-up, the relationship assumed a positive linear associa-
tion. The estimates for the highest category increased in
magnitude and remained significant. Overall, changes in
estimates for the lowest categories for all three measures were
minimal after exclusion of pre-existing disease and smoking;
major alterations only occurred following exclusion of over
half the subjects and almost 90% of the deaths. Therefore,
results are reported for all participants with complete cases
in this study. The independent exclusion of ever smokers
generated a similar magnitude of change in estimates as
when it was applied sequentially. When only respondents
464 years of age were excluded, estimates in the main
models were largely unaltered (Supplementary Tables
12–16). The principal alteration was an increase in the HR
estimate for underweight BMI in almost all models. Inde-
pendent exclusion of the other two restrictions had minimal
influence on estimates (data not shown).
Fractional polynomials
The association between continuous BMI and all-cause
mortality was U shaped (fitted using two-term fractional
polynomials), the nadir was in the region of 25–30kgm
 2
(Figure 1; Supplementary Table 18). HR point estimates (95%
confidence interval) for the midpoints of the BMI categories,
with the mean of the desirable weight category as refer-
ence, were: underweight (14.25kgm
 2)¼4.80 (3.45–6.67),
Table 4 Multilevel, multivariate adjusted hazard ratios for all-cause mortality in different body mass index categories adjusted separately by social class and area of
deprivation
Hazard ratio (95% CI)
BMI model
a BMI model adjusted for social class
a BMI model adjusted for deprivation
a
BMI (kgm
 2)
o18.5 (underweight) 2.63 (1.95–3.55) 2.60 (1.93–3.51) 2.56 (1.90–3.46)
18.5–o25 (desirable weight) 1 1 1
25–o30 (overweight) 0.80 (0.70–0.91) 0.79 (0.70–0.91) 0.80 (0.70–0.91)
X30 (obese) 0.93 (0.80–1.07) 0.91 (0.78–1.05) 0.91 (0.79–1.06)
Individual social class
I/II-professional/managerial F 1 F
III-skilled non-manual F 1.21 (1.00–1.46) F
III-skilled manual F 1.60 (1.36–1.89) F
IV-partly skilled F 1.61 (1.35–1.92) F
V-unskilled F 1.53 (1.23–1.89) F
Other F 1.55 (1.14–2.10) F
Carstairs area of deprivation
1-Least deprived FF 1
2 FF 1.07 (0.88–1.31)
3 FF 1.09 (0.90–1.33)
4 FF 1.37 (1.12–1.68)
5-Most deprived FF 1.63 (1.35–1.97)
Random Estimate s.e. Estimate s.e. Estimate s.e.
Variance at postcode sectors level 0.03 0.03 0.02 0.03 0.003 0.03
n 20117 20117 20106
Deaths 1280 1280 1279
Abbreviations: 95% CI, 95% confidence interval; BMI, body mass index; s.e., standard error.
aBMI model: BMI categories adjusted for age, gender, smoking status,
alcohol consumption and survey year.
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 2)¼0.81 (0.76–0.86) and obese
(45.00kgm
 2)¼1.56 (1.18–2.08) (Supplementary Table 17).
The analyses for WC and WHR were stratified by gender,
as significant interactions were identified between these
variables. For both genders, a U-shaped relationship was
identified for the association of WC with all-cause mortality
Table 5 Multilevel, multivariate adjusted hazard ratios for cause specific mortalities for categories of (a) body mass index, (b) waist circumference and (c) waist-hip
ratio.
(a) Body mass index
Cause of death Hazard ratio (95% CI) BMI (kgm
 2)
a
o18.5
(underweight)
18.5–o25
(desirable weight)
25–o30
(overweight)
X30
(obese)
All-cause 2.63 (1.95–3.55) 1 0.80 (0.70–0.91) 0.93 (0.80–1.07)
Cardiovascular disease 1.33 (0.62–2.87) 1 1.08 (0.85–1.37) 1.36 (1.05–1.77)
Coronary heart disease 1.53 (0.62–3.80) 1 1.09 (0.81–1.48) 1.33 (0.96–1.85)
Other cardiovascular disease 1.01 (0.24–4.19) 1 1.05 (0.71–1.56) 1.41 (0.93–2.14)
Cancer 1.97 (1.13–3.42) 1 0.75 (0.60–0.94) 0.91 (0.72–1.16)
Lung cancer 1.94 (0.81–4.63) 1 0.72 (0.49–1.05) 0.70 (0.44–1.11)
Obese related cancer 1.54 (0.48–4.96) 1 0.92 (0.63–1.33) 1.01 (0.67–1.51)
Other cancer 2.20 (0.88–5.51) 1 0.66 (0.45–0.97) 1.04 (0.71–1.54)
Non-cancer, non-CVD 4.51 (3.00–6.80) 1 0.65 (0.51–0.82) 0.63 (0.48–0.84)
Chronic respiratory disease 3.17 (1.39–7.21) 1 0.43 (0.26–0.73) 0.25 (0.12–0.55)
Acute respiratory disease 11.68 (5.01–27.21) 1 0.59 (0.30–1.14) 0.97 (0.49–1.90)
Injury 1.46 (0.19–11.18) 1 0.71 (0.37–1.38) 0.57 (0.24–1.36)
Miscellaneous 3.82 (2.01–7.27) 1 0.80 (0.58–1.10) 0.80 (0.55–1.17)
(b) Waist circumference
Cause of death Hazard ratio (95% CI) WC (cm)
a
M o79 W o68
(low)
M 79–o94 W 68–o80
(reference)
M 94–o102 W 80–o88
(moderate)
M X102 W X88
(high)
All-cause 1.63 (1.30–2.04) 1 0.90 (0.77–1.05) 1.17 (1.02–1.34)
Cardiovascular disease 0.85 (0.50–1.46) 1 1.08 (0.82–1.41) 1.41 (1.11–1.79)
Coronary heart disease 1.13 (0.61–2.10) 1 1.06 (0.75–1.50) 1.59 (1.18–2.16)
Other cardiovascular disease 0.43 (0.13–1.38) 1 1.11 (0.73–1.68) 1.15 (0.79–1.70)
Cancer 1.96 (1.38–2.78) 1 0.97 (0.75–1.26) 1.22 (0.97–1.54)
Lung cancer 2.44 (1.38–4.31) 1 0.97 (0.61–1.54) 0.99 (0.64–1.53)
Obese related cancer 1.86 (0.99–3.48) 1 1.05 (0.67–1.64) 1.45 (0.98–2.15)
Other cancer 1.53 (0.81–2.89) 1 0.93 (0.60–1.44) 1.26 (0.86–1.84)
Non-cancer, non-CVD 1.91 (1.34–2.72) 1 0.66 (0.49–0.89) 0.91 (0.70–1.17)
Chronic respiratory disease 2.39 (1.18–4.84) 1 0.68 (0.36–1.28) 0.59 (0.33–1.06)
Acute respiratory disease 2.75 (1.12–6.74) 1 0.79 (0.37–1.68) 1.17 (0.62–2.20)
Injury 1.95 (0.79–4.80) 1 0.48 (0.18–1.32) 1.07 (0.49–2.34)
Miscellaneous 1.33 (0.77–2.31) 1 0.67 (0.45–1.01) 0.98 (0.70–1.39)
(c) Waist-hip ratio
Cause of death Hazard ratio (95% CI) WHR
a
M o0.85 W o0.7
(low)
M 0.85–o0.95 W 0.7–o0.8
(reference)
M 0.95–o1 W 0.8–o0.85
(moderate)
M X1WX0.85
(high)
All-cause 1.23 (0.95–1.58) 1 1.10 (0.95–1.26) 1.34 (1.16–1.55)
Cardiovascular disease 0.66 (0.37–1.16) 1 1.22 (0.95–1.55) 1.44 (1.12–1.85)
Coronary heart disease 0.63 (0.30–1.29) 1 1.24 (0.91–1.69) 1.45 (1.06–2.00)
Other cardiovascular disease 0.71 (0.28–1.77) 1 1.17 (0.79–1.75) 1.42 (0.95–2.12)
Cancer 1.61 (1.09–2.38) 1 1.09 (0.86–1.38) 1.26 (0.99–1.61)
Lung cancer 1.29 (0.63–2.66) 1 0.75 (0.48–1.19) 1.15 (0.75–1.77)
Obese related cancer 1.39 (0.65–2.94) 1 1.39 (0.93–2.08) 1.56 (1.04–2.36)
Other cancer 1.94 (1.07–3.51) 1 1.18 (0.80–1.75) 1.12 (0.74–1.70)
Non-cancer, non-CVD 1.39 (0.91–2.12) 1 0.98 (0.75–1.28) 1.33 (1.02–1.74)
Chronic respiratory disease 2.14 (0.80–5.75) 1 1.23 (0.66–2.28) 1.74 (0.96–3.16)
Acute respiratory disease 1.91 (0.70–5.23) 1 1.55 (0.83–2.90) 1.06 (0.51–2.19)
Injury 0.87 (0.32–2.37) 1 0.59 (0.24–1.46) 1.14 (0.47–2.78)
Miscellaneous 1.05 (0.55–1.99) 1 0.87 (0.60–1.27) 1.36 (0.95–1.95)
Abbreviations: 95% CI, 95% confidence interval; BMI, body mass index; WC, waist circumference; WHR, waist-hip ratio; CVD, cardiovascular disease; M, men;
W, women.
aAdjusted for age, gender, smoking status, alcohol consumption and survey year.
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For both, the nadir was at the upper limit of the reference
categories used in the categorical analyses. For WHR the
association, for both men and women, was best described
using a linear relationship; a steeper gradient was identified
for women, whereas for men, there was no significant
association (Supplementary Figure 2; Supplementary Tables
21 and 22). A linear relationship for age was deemed most
appropriate in all these models.
Discussion
We investigated the association of three proxy measures of
adiposity with mortality using the SHeSs-linked data. It is
widely accepted from epidemiological studies that obesity, as
defined by BMI, is associated with increased mortality.
3,5,24
It was therefore surprising that this association was not
identified in this study; in fact, it was suggestive of a slightly
protective relationship. The use of fractional polynomials in
our data identified that the risk of death did not substantially
increase until BMI440kgm
 2 (morbid obesity). It has been
recognized that even among those classed as obese, the
excess mortality is principally confined to those who are
morbidly obese.
25 A number of studies that, like the SHeSs,
have used cohorts recruited in more recent times have
identified an attenuation of the mortality risk associated
with BMI-defined obesity
2,18,26,27 compared with those with
historically older cohorts.
3,24 In Flegal and colleagues’ study,
the obesity associated mortality risk was higher in the
earliest recruited cohort than in later cohorts. Mortality
among the obese category of BMI, and the high categories of
WC and WHR, was largely restricted to CVD in our study,
and in many others.
3,5,7,28 There has been a secular decline
in CVD mortality as a result of changes in CVD risk factors,
for example reduced smoking, and advances in medical
care.
2,29 In Scotland, the mortality rate from ischemic heart
Table 6 Sensitivity analyses involving multilevel, multivariable adjusted hazard ratios for categories of (a) body mass index, (b) waist circumference and (c) waist-
hip ratio following sequential exclusion of 1. individuals with a diagnosis prior to interview of cancer or cardiovascular disease, 2. smokers and ex-smokers,
3. individuals who died within two years of interview and 4. individuals over 64 years of age
(a) body mass index
n Deaths Hazard ratio (95% CI) BMI (kgm
 2)
a
o18.5
(underweight)
18.5–o25
(desirable weight)
25–o30
(overweight)
X30
(obese)
Full sample 20117 1280 2.63 (1.95–3.55) 1 0.80 (0.70–0.91) 0.93 (0.80–1.07)
Sequential exclusions:
Cancer and CVD 18826 978 2.54 (1.82–3.55) 1 0.75 (0.65–0.87) 0.87 (0.74–1.03)
Ever smokers 8024 214 2.71 (0.84–8.70) 1 0.68 (0.49–0.95) 0.94 (0.67–1.32)
Death within 2yrs 7995 185 3.85 (1.19–12.49) 1 0.83 (0.58–1.19) 1.07 (0.73–1.56)
Individuals 464yrs 7268 126 4.52 (1.06–19.18) 1 1.02 (0.66–1.59) 1.09 (0.67–1.78)
(b) waist circumference
n Deaths Hazard ratio (95% CI) WC (cm)
a
M o79 Wo68
(low)
M 79–o94 W 68–o80
(reference)
M 94–o102 W 80–o88
(moderate)
M X102 WX88
(high)
Full sample 17867 1220 1.63 (1.30–2.04) 1 0.90 (0.77–1.05) 1.17 (1.02–1.34)
Sequential exclusions:
Cancer and CVD 15 730 921 1.64 (1.28–2.10) 1 0.92 (0.77–1.10) 1.12 (0.96–1.31)
Ever smokers 7024 204 1.24 (0.64–2.43) 1 0.91 (0.63–1.34) 1.34 (0.96–1.88)
Death within 2yrs 7024 180 1.00 (0.45–2.21) 1 0.98 (0.66–1.47) 1.46 (1.03–2.09)
Individuals 464yrs 6520 123 0.87 (0.34–2.22) 1 1.04 (0.64–1.68) 1.63 (1.06–2.50)
(c) waist-hip ratio
n Deaths Hazard ratio (95% CI) WHR
a
M o0.85 Wo0.7
(low)
M 0.85–o0.95 W 0.7–o0.8
(reference)
M 0.95–o1 W 0.8–o0.85
(moderate)
M X1W X0.85
(high)
Full sample 17840 1218 1.22 (0.95–1.58) 1 1.10 (0.95–1.26) 1.34 (1.16–1.55)
Sequential exclusions:
Cancer and CVD 15708 919 1.19 (0.89–1.58) 1 1.14 (0.96–1.34) 1.34 (1.13–1.58)
Ever smokers 7013 203 1.18 (0.62–2.23) 1 1.43 (1.01–2.03) 1.86 (1.30–2.66)
Death within 2yrs 7013 180 0.81 (0.37–1.76) 1 1.44 (1.00–2.07) 1.83 (1.26–2.67)
Individuals 464yrs 6511 123 0.73 (0.31–1.72) 1 1.29 (0.83–2.01) 1.76 (1.10–2.80)
Abbreviations: 95% CI, 95% confidence interval; BMI, body mass index; WC, waist circumference; WHR, waist-hip ratio; CVD, cardiovascular disease; M, men;
W, women.
aAdjusted for age, gender, smoking status, alcohol consumption and survey year.
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deaths in 1981 to 306 (31%) in 2001 among men; for
women, the rate has reduced from 343 (40%) to 191 (30%).
30
This would go some way to explain the weakening in the
association between obesity and all-cause mortality when
comparing recent and historic studies. Some researchers
have refuted such a secular trend
31 but based their evidence
on a single cohort, not on a number of independent
cohorts.
32
Historically, recent studies will also tend to have shorter
length of follow-up; in the current study, the maximum was
12 years 9 months. The burden of obesity might take a
relatively long time to demonstrate a detrimental association
with mortality, thus requiring a long follow-up.
33 The ideal
length of follow-up is difficult to determine as a long time
between baseline and follow-up can result in increased
misclassification error. It has been proposed that X15 years
is required before obesity will have its full effect on CVD
mortality.
34 One study, with an average of 5.7 years of
follow-up, identified no association using BMI but did using
other measures of fat proportion.
26 The highest categories
of WC or WHR were associated with increased all-cause
mortality in this study. These two indices are thought to
identify individuals with increased risk from obesity-related
illness.
16 According to Lean et al.,
17 the highest category of
WC identifies individuals requiring intervention to prevent
health problems. This association with increased mortality
may reflect the ability of these measures, unlike BMI, to
assess the distribution of body fat and in particular visceral
fat accumulation.
35,36 It has been proposed that the
increased mortality risk associated with excess body fat is
to some degree due to visceral adiposity.
37 Abdominal
obesity is associated with metabolic syndrome and the
consequent elevation in CVD risk factors.
38 WC and WHR
have been identified as being stronger predictors of all-cause
mortality than BMI.
18,26,28 There is evidence that both are
superior to BMI in the identification of CVD risk factors
35,39
and in the prediction of CVD events.
40,41 If these circum-
ferential measures better reflect CVD mortality risks then it
could be expected that these measures would also have
superior performance for all-cause mortality.
Reis et al.
42 identified a high correlation between WC and
BMI and suggested this could imply WC is not only an
indicator of abdominal adiposity but also overall obesity;
WHR had a weaker correlation with BMI, perhaps indicating
that it provides more unique information on fat distribution.
WC reflects abdominal or intra-abdominal fat, whereas hip
circumference reflects gluterofemerol muscle, bone and fat
mass. It is the biological significance of the latter that is hard
to deduce and consequently the exact meaning of WHR is
unclear.
43 In addition, WHR can be the same for the lean and
the very obese. In our study, the highest category of WHR
provided the strongest association with all-cause mortality.
The relatively strong linear relationship for continuous WHR
with all-cause mortality for women has been reported
elsewhere.
18,26 Whether WC or WHR is the better measure
is often debated; frequently, there is only a marginal
difference in performance. Comparison is difficult as studies
have often concentrated on certain age or gender groups as
well as used different methodology, including different
covariate categorization. Both WC and WHR have the
potential for greater measurement error than BMI, although
WC requires only one measurement. These two indices on
their own, or in combination with BMI, could better capture
the health risks of increased adiposity.
44
Overweight as defined by BMI was not associated with
an increased risk of mortality. This finding is similar to a
number of other studies.
2,27,45 BMI is believed to be a
surrogate measure of general adiposity, but it is unable to
distinguish between fat mass and lean mass, particularly for
men and the elderly.
46 Individuals within the overweight
category may be fit and muscular rather than having excess
fat. Although this might explain the decreased mortality
associated with overweight in our analyses, it does not
explain the lack of association between obesity and mortal-
ity. In the elderly, where most deaths occur, misclassification
by BMI may occur because muscle mass tends to be replaced
with fat mass as we age.
37 BMI has been demonstrated to
misclassify X50% individuals with excess fat as being within
desirable or just inside overweight categories, whereas those
with healthy fat levels may be classified as being overweight
or obese.
46,47 This misclassification could attenuate the
apparent impact of excess adiposity on mortality. Fitting
Figure 1 Functional form of the association of BMI with the relative hazard
of death estimated in a Cox proportional hazards model adjusted for age,
gender, smoking, alcohol consumption and survey year. The function was
fitted using two-term fractional polynomial functions with powers (log, log).
The function was standardized such that the HR was 1 at the mean of
the desirable weight category for BMI (18.5–o25kgm
 2)¼22.57kgm
 2.
Dot-dash lines indicate the 95% confidence interval.
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fractional polynomials identified the nadir of the relation-
ship with all-cause mortality to be in the overweight region,
with decreased hazard of death commencing at the upper
end of the desirable weight category and continuing into the
obese category. Despite these findings, and arguments,
overweight has been associated with an increased risk of
mortality by some researchers.
48 Even if overweight is not
linked to increased mortality it appears to be, along with
obesity, associated with elevated morbidity.
45,49
A protective effect of an elevated BMI, known as the
‘obesity paradox’, has been demonstrated in patients with
chronic heart failure.
50 Recently, a U-shaped relationship for
this has been described with increased mortality among the
underweight and those with a BMI445kgm
 2.
51 Being
overweight has also been shown to be protective in those
over 65 years of age.
42,52–54 There were no significant
interactions between age and any of the anthropometric
measurements in this study. In addition, our sensitivity
analyses, where we investigated age stratification or exclu-
ded those over 64 years of age, did not alter estimates to any
great extent. Importantly, this age restriction confined the
sample to the age group common to all three surveys (that is
18–64 years). The consequent minimal change in estimates
encouraged us to include the older age groups from the later
surveys in our analyses to maximize power. However, it is
recognized that we were unable to fully explore the possible
influence of old age on the relationship between body size
mortality because of the relative scarcity of individuals from
the older age group. The stage at which overweight or
obesity occurs in the life course is undoubtedly important.
Men who were overweight or obese in late adolescence were
more likely to have a premature death in one study.
55 In
another, it was demonstrated that an individual overweight
or obese in midlife, combined with weight loss in later life,
may have the greatest mortality risk in old age.
56 Such
complex dynamics might serve to mask the harmful effects
of overweight and obesity in epidemiological studies.
The inability of BMI to distinguish between fat mass and
lean mass may also explain the increased risk for all-cause
mortality associated with the underweight in this study and
others.
2,45 One hypothesis is that fat mass is positively
associated with mortality, whereas fat-free mass follows a
negative relationship; that is a lack of lean mass can be
detrimental.
57 An alternative explanation for the increased
mortality associated with the underweight, and the attenua-
tion of the impact of overweight or obesity on mortality, is
that residual confounding (effect modification) has not
been correctly accounted for.
58 This residual confounding
is principally described as relating to smoking and pre-
existing (occult) illness (although unknown confounders
could also be responsible). Using a novel approach it has
recently been demonstrated that the increased mortality
associated with a low BMI might well be due to residual
confounding.
59 The exclusion of all smokers, pre-existing
illness and early death during follow-up has been suggested
to account for this problem.
60 However, the sensitivity
analyses performed in our investigation, and by other
researchers, would not always support these claims.
5,61 One
difficulty is that the exclusion of so many cases results in the
loss of precision and power. A growing number of studies
have advised against the use of exclusions to account for
residual confounding.
62–65 Instead of treating it as an
artefact, a low BMI, even within the healthy spectrum, could
be associated with increased mortality.
66
This is not the only study to find that underweight, as
defined by BMI, was associated primarily with non-cancer
and non-CVD mortality.
7 To a lesser extent, this was also true
for the lowest WC category. Respiratory disease, both acute
and chronic, would appear to be largely responsible for this
finding, concurring with a number of other investiga-
tions.
3,5,7 In the current analyses, there was an increased
HR related to cancer mortality for the lowest category of all
three measures, the remaining categories having no associa-
tion. The relationships reported by previous studies have
been inconsistent. This has included: a weak or no associa-
tion with body size,
7,18 a stronger positive relationship for
women and a relatively weak relationship for men
24 and a
positive association for women (BMI435kgm
 2) and an
increased risk for underweight and obese men.
5 WHR was
the sole identifier of the increased risk of adiposity with
obesity-related cancer mortality. Previously, obesity-related
cancer mortality had been predicted by a BMIX30kgm
 2 in
one large sample.
7
In developed countries, the relationship between socio-
economic status and obesity has been shown to have an
inverse association among women and to be inconsistent
for men.
11 One Scottish study demonstrated this inverse
relationship for both men and women.
67 In our study,
despite there being evidence of social inequalities in
mortality, there was limited support for deaths associated
with body size being explained to any great extent by such
inequalities. This concurs with a previous study investigating
social inequalities in mortality, which did not identify any
differences in the influence of risk factors (that included
BMI) at different levels of education.
68 Others have sug-
gested that some, but by no means all, of the socioeconomic
differential in mortality can be explained by smoking
and BMI.
69
Direct measurements were used to create the anthropo-
metric indices thus eliminating any bias associated with self-
reporting, namely BMI is increasingly under reported as
actual BMI increases.
70 The thresholds for the indices used in
this study are somewhat arbitrary in nature, chiefly being
derived from informed opinion under the umbrella of the
WHO.
16 Therefore, they may not be the optimum for
determining the recommendations for a healthy weight.
Although not practical, in epidemiological surveys, body fat
proportion can be directly measured, for example using dual-
energy x-ray absorption. Additionally, cutoff selection is
problematic because obesity is defined as excess body fat but
when this continuum becomes detrimental is unclear. It is
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WHR represent biologically.
One of this study’s strengths is that it used data from
nationally representative surveys. Thus, the results may
better reflect the general population than those from cohorts
consisting of volunteers or those from select populations.
It has been noted that estimated mortality risks from
representative surveys have often been lower than those
from such cohort studies.
27,62 The wide-ranging nature of
the SHeSs permitted adjustment for a number of potentially
confounding variables. Despite this, because of the observa-
tional nature of the study, we cannot exclude the possibility
of residual confounding caused by unmeasured or imper-
fectly measured confounders. Error is also associated with
the use of death certificates that might not reflect the actual
cause, or the underlying diseases, that resulted in death. We
did not adjust for physical activity or diet in this study as
these could be considered to be on the causal pathway to
obesity. Further, cholesterol and other biological markers
were not adjusted for, as these are likely to be causal in CVD.
Only individuals living in private households were surveyed,
those living in communal establishments, such as residential
care and prisons or those in the armed forces, will have
been excluded. There is potential bias as a result of attrition
from non-response to the original interview, non-consent to
data linkage and refusal of the nurse visit. The declining
response proportion in these surveys is of concern and
brings into question how nationally representative they are;
especially the most recent survey. We do believe the response
proportion to the first two surveys to be relatively robust.
Sensitivity analyses using survey weights that accounted for
differential response did not alter estimates substantially.
Unfortunately, it is not possible to assess differences between
responders and non-responders using these data.
The largest component of missing data was for the
anthropometric indices, particularly for the waist and hip
measurements as they were conducted during the nurse visit.
Complete data sets were created for use in analyses through
multiple imputation thus avoiding potential bias that could
arise through complete case analyses.
71 We believe our
exploratory analyses demonstrated a strong association
between a range of demographic and health behaviour
variables and missing data for BMI, WC and WHR. This
suggests that our assumption that the missing mechanism
for the anthropometric measures missing at random was
reasonable. The estimates generated from the imputed data
sets were similar to those in the complete case models,
suggesting that the information lost by missing cases
would not have had a major influence. There was no ability
to assess changes in health behaviour either prior to
or subsequent to the data capture, for example weight loss
or weight gain. However, information was available from
the data linkage concerning previous hospital admissions
or cancer registrations. Individuals were assumed to be alive
if they did not have a death record and this could lead
to misclassification of e ´migre ´s who subsequently died.
However, there is low emigration from Scotland and analyses
limited to those on the CHI did not generate substantially
different estimates.
It is important that as further follow-up becomes available
from the SHeS-linked data that the associations between
mortality and body size are re-analysed. The SHeS is being
conducted on an annual basis from 2008 to 2011 and as data
from these becomes available it should be possible to
increase sample size and perhaps assess secular changes in
the relationship between mortality and weight. Our results
reaffirm that the mortality associated with obesity is
predominately linked to CVD. Further analyses would be
pertinent in light of the proposed influence on this relation-
ship of recent improvements in medical care or changes in
the prevalence of other risk factors. In conducting epide-
miological studies investigating the impact of adiposity on
health it would be prudent not to be completely reliant on
BMI and to consider alternatives, which should include WC
and WHR.
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